Cancer Immunotherapies

Programm

• 09:15 45 Min. 15 Min.

  • Keynote Lecture

  Updates with CAR T for cancer

  • Carl June (Philadelphia, PA / US)
• 10:15 20 Min. 5 Min.

  • Invited Lecture

  The immunopeptidome landscape associated with T cell infiltration, inflammation and immune-editing in lung cancer

  • Michal Bassani-Sternberg (Lausanne / CH)
• 10:40 20 Min. 0 Min.

  Coffee Break
• 11:00 12 Min. 3 Min.

  • Abstract Lecture

  Survival of glioblastoma patients treated with personalized peptide vaccines

  • Saskia Biskup (Tübingen / DE)

   Cancer immunotherapies
• 11:15 12 Min. 3 Min.

  • Abstract Lecture

  TCRmimic CAR T cells – opportunities and challenges from target selection to target abundance

  • Martin Klatt (Berlin / DE)

   Cancer immunotherapies
• 11:30 12 Min. 3 Min.

  • Abstract Lecture

  Clinical development of the bispecific PSMAxCD3 antibody CC-1 in patients with prostate and lung cancer

  • Jonas S. Heitmann (Tübingen / DE)

   Cancer immunotherapies
• 11:45 12 Min. 3 Min.

  • Abstract Lecture

  Harnessing the organoid technology in combination with CRISPR to study cancer immunosurveillance

  • Tatjana Bilich (Palo Alto / US)

   Other topics